Clinical Trial Update: Morbidity and Mortality Follow Up for the Scleroderma Lung Study

View source ↗

Summary

This release provides morbidity and mortality follow-up data from the Scleroderma Lung Study, presenting long-term outcomes for participants.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Sclerosis

Snippet

Sponsor: Duke University | Conditions: Scleroderma | Status: COMPLETED